IMVOTAMAB
UNII F3HG38I0T1

Substance Identification & Data

This profile provides standardized clinical and technical data for Imvotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F3HG38I0T1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2573121-53-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F3HG38I0T1

CAS Registry Number

2573121-53-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IMVOTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C165166

National Cancer Institute reference terminology for clinical and research data.

INN ID

12054

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-34

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imvotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMVOTAMAB

Common Names & Synonyms

ANTI-CD20/ANTI-CD3 BISPECIFIC IGM ANTIBODY IGM2323

IMMUNOGLOBULIN M, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN .MU.-CHAIN), DISULFIDE WITH HUMAN .KAPPA.-CHAIN, DECAMER, (574'->271),(574''''''''''->325)-BIS(DISULFIDE) WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN SINGLE-CHAIN FV FRAGMENT VH-(GGGGS)3-VL) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN J CHAIN (HUMAN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH SERUM ALBUMIN (HUMAN)

IMVOTAMAB [INN]

IMVOTAMAB [USAN]

IMVOTAMAB [WHO-DD]